Glocentrica Ltd
A bioscience company dedicated to improving glycemic health and healthy aging
Pioneering research on glyoxalase 1 inducers and AGEomics
Our Flagship Products and Services
GlucoRegulate (Glo1 inducer)
Our team optimized dietary supplements activating master health protective transcription factor Nrf2 to reset dysfunctional glucose metabolism in insulin resistance and obesity. The optimized supplement, trans-resveratrol and hesperetin combination, improved glucose control and corrected insulin resistance in clinical trial. We patented the supplement and offer it as the premium supplement “GlucoRegulate” by Glovitality (UK) Ltd.
Protein glycation “AGEomics”
Our team pioneered the assay of protein modifications by glycation, oxidation and nitration, quantifying over 20 different modifications and 21 unmodified amino acids precursors concurrently using stable isotope dilution analysis liquid chromatography-tandem mass spectrometry (LC-MS/MS). This is now the gold standard analytical platform. It supports assay of methylglyoxal-derived protein glycation targeted by Glo1 inducer and many other therapeutics applications.
Partnering and consultancy
We uniquely hold patents on Glo1 inducer technology, experimental and clinical evaluation data and related know-how. We welcome opportunities to partner the development of Glo1 inducers to widen increased availability to the extraordinary health benefits.
Glocentrica vision
At Glocentrica Ltd, we encourage innovation, technical expertise, collaboration and partnering in discovery, validation and commercial development. We achieve success by acting with integrity, transparency and dedication. Our vision is to improve global glycemic health and healthy aging to enhance the quality of all human lives.